XIST

ncRNA information

ncRNA name

XIST

Specific or universal ncRNAs

Universal ncRNAs

Class

Long noncoding RNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

let-7i/BAG-1

Cancer information

Cancer name

Lung Adenocarcinoma

Cancer site

Lung

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Up

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

LncRNA XIST overexpression in A549 cells increased their chemosensitivity to cisplatin both in vitro and in vivo by protecting cells from apoptosis and promoting cell proliferation.

Tissue resource

lung adenocarcinomaand matched-normal tissue samples

human lung adenocarcinoma cell lines A549

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

China-Japan Union Hospital of Jilin University

American Type Culture Collection

Country

China

USA

Continent

Asia

Amercia